SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007860
Filing Date
2022-05-09
Accepted
2022-05-09 16:44:50
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q olma-20220331x10q.htm   iXBRL 10-Q 1569915
2 EX-31.1 olma-20220331xex31d1.htm EX-31.1 13580
3 EX-31.2 olma-20220331xex31d2.htm EX-31.2 13351
4 EX-32.1 olma-20220331xex32d1.htm EX-32.1 10409
  Complete submission text file 0001558370-22-007860.txt   5661466

Data Files

Seq Description Document Type Size
5 EX-101.SCH olma-20220331.xsd EX-101.SCH 33649
6 EX-101.CAL olma-20220331_cal.xml EX-101.CAL 47096
7 EX-101.DEF olma-20220331_def.xml EX-101.DEF 99366
8 EX-101.LAB olma-20220331_lab.xml EX-101.LAB 355174
9 EX-101.PRE olma-20220331_pre.xml EX-101.PRE 254898
55 EXTRACTED XBRL INSTANCE DOCUMENT olma-20220331x10q_htm.xml XML 870550
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39712 | Film No.: 22905763
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences